Congenital retinal arteriovenous communication

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:353334Q14.1
Who is this for?
Show terms as
1FDA treatments8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital retinal arteriovenous communication (also known as congenital retinal arteriovenous malformation, or retinal racemose hemangioma) is a rare eye condition that is present from birth. In this condition, there are abnormal direct connections between the arteries and veins in the retina — the light-sensitive tissue at the back of the eye. Normally, blood flows from arteries through tiny capillaries before reaching veins, but in this condition, blood bypasses the capillaries and flows directly from arteries into veins. These abnormal blood vessel connections can vary widely in severity. In mild cases, a person may have no symptoms at all and the condition is found only during a routine eye exam. In more severe cases, the enlarged, twisted blood vessels can affect vision by damaging the retina or causing complications such as bleeding, blood vessel blockage, or swelling. When this condition occurs along with similar blood vessel malformations in the brain and face, it may be part of a broader syndrome called Wyburn-Mason syndrome (also known as Bonnet-Dechaume-Blanc syndrome). There is currently no cure for this condition. Treatment is generally focused on monitoring the eyes and managing any complications that arise. In many cases, especially mild ones, no treatment is needed. For more severe cases, laser therapy or other interventions may be considered, though treatment options remain limited.

Also known as:

Key symptoms:

Abnormally enlarged and twisted blood vessels in the retinaDecreased vision or blurry visionVision loss in one eyeNo symptoms in mild cases (found incidentally during eye exam)Bleeding in the retinaSwelling of the retinaBlockage of retinal blood vesselsVisual field defects (blind spots)Possible associated brain blood vessel malformations if part of Wyburn-Mason syndrome

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

1 available

TOBRADEX ST

TOBRAMYCIN / DEXAMETHASONE· Harrow Eye, LLC

They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.

No actively recruiting trials found for Congenital retinal arteriovenous communication at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital retinal arteriovenous communication community →

No specialists are currently listed for Congenital retinal arteriovenous communication.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital retinal arteriovenous communication.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital retinal arteriovenous communicationForum →

No community posts yet. Be the first to share your experience with Congenital retinal arteriovenous communication.

Start the conversation →

Latest news about Congenital retinal arteriovenous communication

1 articles
NewsFDA
FDA Approves TOBRADEX ST
TOBRADEX ST (DEXAMETHASONE) received FDA approval.
See all news about Congenital retinal arteriovenous communication

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is the arteriovenous malformation in my eye, and what grade is it?,Is my vision at risk of getting worse over time?,Should I be screened for blood vessel malformations in the brain (Wyburn-Mason syndrome)?,How often do I need follow-up eye exams?,Are there any activities or situations I should avoid to protect my vision?,What signs or symptoms should prompt me to seek emergency care?,Are there any new treatments or clinical trials available for this condition?

Common questions about Congenital retinal arteriovenous communication

What is Congenital retinal arteriovenous communication?

Congenital retinal arteriovenous communication (also known as congenital retinal arteriovenous malformation, or retinal racemose hemangioma) is a rare eye condition that is present from birth. In this condition, there are abnormal direct connections between the arteries and veins in the retina — the light-sensitive tissue at the back of the eye. Normally, blood flows from arteries through tiny capillaries before reaching veins, but in this condition, blood bypasses the capillaries and flows directly from arteries into veins. These abnormal blood vessel connections can vary widely in severity.

How is Congenital retinal arteriovenous communication inherited?

Congenital retinal arteriovenous communication follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Congenital retinal arteriovenous communication typically begin?

Typical onset of Congenital retinal arteriovenous communication is neonatal. Age of onset can vary across affected individuals.